NCT06223763 2024-01-25
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
Unknown
Clinical Trials
31 trialsNCT02489006 2024-01-17
NEO
University Health Network, Toronto
Phase 2 Unknown
NCT05065021 2024-01-17
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
University Health Network, Toronto
Phase 2 Unknown
NCT06161272 2023-12-07
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Guangxi Medical University
Phase 2 Unknown
NCT05960630 2023-11-18
MIRRORS-RCTP
Royal Surrey County Hospital NHS Foundation Trust
Phase NA Unknown
NCT03363867 2023-08-07
BEACON
Peter MacCallum Cancer Centre, Australia
Phase 2 Unknown
NCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT05792254 2023-03-31
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer
Ruijin Hospital
Phase NA Unknown
NCT03321188 2023-02-06
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
Phase 2 Unknown
NCT03430700 2023-01-30
PROMPT
University College, London
Phase 2 Unknown
NCT02125513 2022-12-30
GOGER-01
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2 Unknown
NCT05665023 2022-12-29
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
Yonsei University
Phase 2 Unknown
NCT03540017 2022-11-02
HIPEC After Initial CRS in Patients Who Have Received NACT
Northwell Health
Phase 1 Unknown
NCT05537844 2022-09-23
BriTROC-2
Cancer Research UK, Glasgow
Unknown
NCT04295577 2022-01-21
MONITOR-UK
Royal Marsden NHS Foundation Trust
Unknown
NCT04375956 2021-12-20
MITO 27
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Unknown
NCT03462212 2021-08-27
MITO25
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 1/2 Unknown
NCT04267575 2021-08-09
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Phase NA Unknown
NCT03000192 2021-03-17
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
University Hospital Southampton NHS Foundation Trust
Unknown
NCT04556071 2020-11-10
AVANIRA3
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04402333 2020-09-02
MIRRORS
Royal Surrey County Hospital NHS Foundation Trust
Unknown
NCT00652119 2020-08-19
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin
Massachusetts General Hospital
Phase 1 Unknown
NCT00499512 2020-01-10
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Unknown
NCT03693248 2019-12-10
ROCOCO
Seoul National University Hospital
Phase 3 Unknown
NCT03373058 2019-11-06
EHTASEOCCS
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT02349958 2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2 Unknown
NCT03283943 2018-07-11
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
British Columbia Cancer Agency
Phase 1 Unknown
NCT03188159 2018-03-29
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
National University Hospital, Singapore
Phase 2 Unknown
NCT03180177 2018-01-24
EHNPCTASEOC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT02328716 2017-12-13
CARCINOHIPEC
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase 3 Unknown
NCT01570582 2012-04-04
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Korean Gynecologic Oncology Group
Phase 2 Unknown